UK markets closed
NIKKEI 225
38,236.07 -37.98 (-0.10%) HANG SENG
18,207.13 +444.10 (+2.50%) CRUDE OIL
78.92 -0.08 (-0.10%) GOLD FUTURES
2,317.60 +6.60 (+0.29%) DOW
38,188.77 +285.48 (+0.75%) Bitcoin GBP
47,389.46 +1,292.68 (+2.80%)
Eli Lilly and Company (LLY)
NYSE - Nasdaq Real-time price. Currency in USD
Add to watchlist
As of 02:13PM EDT. Market open.
| Previous close | 776.75 |
| Open | 777.34 |
| Bid | 758.63 x 1200 |
| Ask | 758.88 x 800 |
| Day's range | 756.16 - 777.01 |
| 52-week range | 419.80 - 800.78 |
| Volume | |
| Avg. volume | 3,116,267 |
| Market cap | 720.217B |
| Beta (5Y monthly) | 0.37 |
| PE ratio (TTM) | 112.10 |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | 5.20 (0.67%) |
| Ex-dividend date | 14 Feb 2024 |
| 1y target est | N/A |
- Yahoo Finance
Novo Nordisk sales up 26% driven by GLP-1s, misses 11% on Wegovy
Novo Nordisk CEO Lars Jørgensen tells Yahoo Finance the company is confident about a robust GLP-1 sales year despite missing Wall Street estimates.
- Barrons.com
Novo Nordisk’s Wegovy Sales More Than Doubled. Why the Stock Is Falling.
The Danish pharmaceutical giant, which became Europe’s most valuable company last year, said Wegovy sales jumped 106% in the first quarter.
- Insider Monkey
Eli Lilly and Company (NYSE:LLY) Q1 2024 Earnings Call Transcript
Eli Lilly and Company (NYSE:LLY) Q1 2024 Earnings Call Transcript April 30, 2024 Eli Lilly and Company beats earnings expectations. Reported EPS is $2.58, expectations were $2.47. Operator: Ladies and gentlemen, thank you for standing by, and welcome to the Lilly Q1 2024 Earnings Call. At this time all participants are in a listen-only mode. […]
© 2024 Yahoo. All rights reserved.